IMVT Competitors & Alternatives
Compare Immunovant Inc with similar stocks in the same industry
Biotechnology
IMVT
Main Stock$35.71
Tradestie Score
43
Market Cap
$2.85B
Analyst Upside
+36.9%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$193.06
|
$8.57B | - | 52 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$24.43
|
$8.53B | 15.4 | 56 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$245.43
|
$8.30B | 72.1 | 43 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$56.18
|
$6.68B | - | 62 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$113.95
|
$6.64B | - | 39 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$90.00
|
$6.38B | - | 62 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$20.41
|
$6.03B | - | 36 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$45.15
|
$6.02B | - | 48 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
More IMVT Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2836)
216 stocks in this industry